U.S. stock futures were lower this morning, with the Dow futures falling around 0.1% on Monday.

Shares of Revolution Medicines Inc (NASDAQ:RVMD) dipped 26.1% to $87.02 in pre-market trading.

The Wall Street Journal Reported that Merck (NYSE:MRK) is no longer in talks to acquire Revolution Medicines.

Revolution Medicines shares dipped 26.1% to $87.02 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• Erasca Inc (NASDAQ:ERAS) fell 11.5% to $8.82 in pre-market trading. Erasca announced closing of upsized public offering of common stock, including full exercise of underwriters’ option to purchase additional shares.
• BlackRock TCP Capital Corp (NASDAQ:TCPC) fell 8.7% to $5.35 in pre-market trading.
• Ambitions Enterprise Management Co LLC (NASDAQ:AHMA) dipped 7.9% to $28.30 in pre-market trading after falling 17% on Friday. Ambitions Enterprise Management recently reported a year-over-year increase in H1 EPS results.
• Regencell Bioscience Holdings Ltd (NASDAQ:RGC) fell 6% to $29.52 in pre-market trading after gaining 2% on Friday.
• Sierra Bancorp (NASDAQ:BSRR) declined 5.8% to $33.02 in pre-market trading.
• Forward Industries Inc (NASDAQ:FWDI) declined 4.6% to $7.46 in pre-market trading
• Argo Blockchain PLC – ADR (NASDAQ:ARBK) fell 3.8% to $4.20 in pre-market trading.
• MINISO Group Holding Ltd – ADR (NYSE:MNSO) declined 3.6% to $19.12 in pre-market trading.
• Corvus Pharmaceuticals Inc (NASDAQ:CRVS) fell 3.2% to $24.17 in pre-market trading. Corvus Pharmaceuticals announced closing of upsized public offering of common stock and full exercise of the underwriters’ option to purchase additional shares, generating gross proceeds of approximately $201 million.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.